These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8875553)

  • 21. Tumor-promoting and tumor-protective effects of high-fat diets on chemically induced mammary cancer in rats.
    Zusman I; Gurevich P; Madar Z; Nyska A; Korol D; Timar B; Zuckerman A
    Anticancer Res; 1997; 17(1A):349-56. PubMed ID: 9066676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
    el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
    Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
    Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
    Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat soluble tumor-associated antigens inhibit chemically-induced mammary tumorigenesis in syngeneic rats.
    Kossoy G; Ben-Hur H; Elhayany A; Schneider DF; Zusman I
    Oncol Rep; 2005 Apr; 13(4):585-8. PubMed ID: 15756427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron repletion attenuates the protective effects of iron deficiency in DMBA-induced mammary tumors in rats.
    Hrabinski D; Hertz JL; Tantillo C; Berger V; Sherman AR
    Nutr Cancer; 1995; 24(2):133-42. PubMed ID: 8584449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative efficacy of the opioid antagonist, naltrexone, on the initiation and promotion phases of rat mammary carcinogenesis.
    Koo KL; Tejwani GA; Abou-Issa H
    Anticancer Res; 1996; 16(4A):1893-8. PubMed ID: 8712718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of caffeine and/or coffee consumption on the initiation and promotion phases of 7,12-dimethylbenz(a)anthracene-induced rat mammary gland tumorigenesis.
    Welsch CW; DeHoog JV; O'Connor DH
    Cancer Res; 1988 Apr; 48(8):2068-73. PubMed ID: 3127044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S; Mevissen M; Löscher W
    Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to flaxseed or its purified lignan during suckling only or continuously does not alter reproductive indices in male and female offspring.
    Ward WE; Chen J; Thompson LU
    J Toxicol Environ Health A; 2001 Dec; 64(7):567-77. PubMed ID: 11760154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human soluble p66 and p51 tumor-associated antigens promote the suppression of rat mammary tumors in comparison to commercial human albumin.
    Kossoy G; Avinoach I; Zusman I; Scheider DP; Ben-Hur H; Elhayany A
    Oncol Rep; 2004 Feb; 11(2):487-91. PubMed ID: 14719088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative contribution of calories from dietary fat, carbohydrate, and fiber in the promotion of DMBA-induced mammary tumors in Sprague-Dawley rats.
    Jackson CD; Weis C; Chen JJ; Bechtel DH; Poirier LA
    Nutr Cancer; 1998; 30(3):194-200. PubMed ID: 9631490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability in anticancer lignan levels in flaxseed.
    Thompson LU; Rickard SE; Cheung F; Kenaschuk EO; Obermeyer WR
    Nutr Cancer; 1997; 27(1):26-30. PubMed ID: 8970178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flaxseed and its mammalian lignan precursor cause a lengthening or cessation of estrous cycling in rats.
    Orcheson LJ; Rickard SE; Seidl MM; Thompson LU
    Cancer Lett; 1998 Mar; 125(1-2):69-76. PubMed ID: 9566698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the flaxseed lignans secoisolariciresinol diglucoside and its aglycone on serum and hepatic lipids in hyperlipidaemic rats.
    Felmlee MA; Woo G; Simko E; Krol ES; Muir AD; Alcorn J
    Br J Nutr; 2009 Aug; 102(3):361-9. PubMed ID: 19216812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of type and amount of dietary fat on the enhancement of rat mammary tumorigenesis by exercise.
    Thompson HJ; Ronan AM; Ritacco KA; Tagliaferro AR
    Cancer Res; 1989 Apr; 49(8):1904-8. PubMed ID: 2495170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural determinants of plant lignans for growth of mammary tumors and hormonal responses in vivo.
    Saarinen NM; Penttinen PE; Smeds AI; Hurmerinta TT; Mäkelä SI
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):209-19. PubMed ID: 15860264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside.
    Rickard SE; Yuan YV; Thompson LU
    Cancer Lett; 2000 Dec; 161(1):47-55. PubMed ID: 11078912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.
    Verma AK; Johnson JA; Gould MN; Tanner MA
    Cancer Res; 1988 Oct; 48(20):5754-8. PubMed ID: 3139283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressive effect of sesamin against 7,12-dimethylbenz[a]-anthracene induced rat mammary carcinogenesis.
    Hirose N; Doi F; Ueki T; Akazawa K; Chijiiwa K; Sugano M; Akimoto K; Shimizu S; Yamada H
    Anticancer Res; 1992; 12(4):1259-65. PubMed ID: 1386971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.